Search results for "symptoms"

showing 10 items of 713 documents

Knowledge expectations of recently diagnosed patients with knee osteoarthritis.

2016

Aim The aim of this study was to assess the socio-demographic and disease-related symptoms and emotions and knowledge expectations of patients recently diagnosed with knee osteoarthritis. A further aim was to determine associations between selected demographic variables and patients' expected knowledge. Background Patient counselling and information provision are recommended for all patients with knee osteoarthritis. In healthcare centres, there is a good possibility to establish the knowledge expectations of patients with knee osteoarthritis during counselling. Recent empirical evidence indicates a lack of research on knowledge expectations among recently diagnosed patients with knee osteo…

CounselingMalemedicine.medical_specialtyHigher educationEmotionsempowering knowledgeOsteoarthritisknee osteoarthritisHospital Patient's Knowledge Expectations Scale03 medical and health sciences0302 clinical medicinenursingPatient Education as TopicSurveys and QuestionnairesHealth careMedicineHumans030212 general & internal medicineHospital patientsEmpirical evidenceGeneral NursingAged030203 arthritis & rheumatologybusiness.industryta3141Pain managementMiddle AgedOsteoarthritis Kneemedicine.diseaseKnowledgePatient SatisfactionVocational educationScale (social sciences)Physical therapysymptomsFemalebusinessJournal of advanced nursing
researchProduct

Effect of a social intervention of choice vs. control on depressive symptoms, melancholy, feeling of loneliness, and perceived togetherness in older …

2016

Objectives: This study examined effects of a social intervention on depressive symptoms, melancholy, loneliness, and perceived togetherness in community-dwelling Finnish older people. Method: Promotion of mental well-being in older people (GoodMood; ISRCTN78426775) was a single-blinded randomized control trial lasting 1.5 years. Two hundred and twenty-three persons aged 75–79 years reporting symptoms of loneliness or melancholy were randomized into intervention and control groups. The intervention group was allowed to choose among supervised exercise, social activity, or personal counseling. Follow-up measurements were conducted at the end of 6-month intervention, and at 3, 6, and 12 months…

CounselingMalemelankoliaAgingvanhuksetIntervention grouplaw.inventionolder people0302 clinical medicineSocial integrationdepressive symptomsRandomized controlled triallawSingle-Blind Method030212 general & internal medicineFinlandmedia_commonDepressionsocial integrationLonelinessta3141ta3142Exercise Therapy3. Good healthPsychiatry and Mental healthOutcome and Process Assessment Health CareFeelingyksinäisyysFemalePshychiatric Mental Healthmedicine.symptomPsychologyRCTikääntyneetClinical psychologymasennusmedia_common.quotation_subject03 medical and health sciencesIntervention (counseling)medicineHumansInterpersonal RelationsseuraelämäDepressive symptomsAgedDepressive Disorder030214 geriatricsLonelinesssosiaalisuussosiaalinen integraatioGeriatrics and GerontologyoireetOlder peopleGerontologyFollow-Up Studies
researchProduct

Effect of Six-Month Diet Intervention on Sleep among Overweight and Obese Men with Chronic Insomnia Symptoms : A Randomized Controlled Trial

2016

Growing evidence suggests that diet alteration affects sleep, but this has not yet been studied in adults with insomnia symptoms. We aimed to determine the effect of a six-month diet intervention on sleep among overweight and obese (Body mass index, BMI >= 25 kg/m(2)) men with chronic insomnia symptoms. Forty-nine men aged 30-65 years with chronic insomnia symptoms were randomized into diet (n = 28) or control (n = 21) groups. The diet group underwent a six-month individualized diet intervention with three face-to-face counseling sessions and online supervision 1-3 times per week; 300-500 kcal/day less energy intake and optimized nutrient composition were recommended. Controls were instruct…

CounselingMaleobesityTime FactorsINTERNATIONAL CLASSIFICATIONOverweightinsomnia symptomsBody Mass Indexlaw.invention0302 clinical medicineRandomized controlled triallawSleep Initiation and Maintenance DisordersSurveys and QuestionnairesInsomniasleep onset030212 general & internal medicineFinlandPOPULATION2. Zero hungerdiet interventionNutrition and Dieteticsylipainota3141Middle AgedWEIGHT-GAINPREVALENCE3. Good healthTreatment OutcomeBALANCESleep diarymedicine.symptomSleep onsetNutritive Valuelcsh:Nutrition. Foods and food supplyAdultmedicine.medical_specialtyDiet ReducingNutritional Statuslcsh:TX341-641Articleuni (lepotila)DISORDERS ICSD03 medical and health sciencesInternal medicineWeight LossReaction TimemedicineHumansQUALITYNocturiaoverweightsleepAgedCaloric Restrictionbusiness.industrynutrientENERGY-EXPENDITUREinsomnia symptoms; sleep; sleep onset; diet intervention; nutrient; overweight; obesity3141 Health care scienceNutrition AssessmentFATRISK-FACTORSPhysical therapylihavuusSleep onset latencybusinessWeight gain030217 neurology & neurosurgeryFood ScienceNutrients
researchProduct

The relationship between health-related quality of life and melancholic depressive symptoms is modified by brain insulin receptor gene network

2021

AbstractTo investigate whether expression-based polygenic risk scores for the insulin receptor gene network (ePRS-IRs) modifiy the association between type of depressive symptoms and health-related quality of life (HRQoL). This cross-sectional study includes 1558 individuals from the Helsinki Birth Cohort Study. Between 2001 and 2004, the Short Form-36 questionnaire was employed to assess mental and physical components of HRQoL and Beck Depression Inventory (BDI) to assess depressive symptoms. Depressive symptoms were categorized into minimal (BDI < 10), non-melancholic and melancholic types of depression. The ePRS-IRs were calculated for the hippocampal (hePRS-IR) and the mesocorticolim…

DISORDERMaleglukoosiaineenvaihduntaelämänlaatuBody Mass Index0302 clinical medicineQuality of lifeSurveys and QuestionnairesMedicineGene Regulatory NetworksDepression (differential diagnoses)METABOLIC SYNDROME2. Zero hunger0303 health sciencesMultidisciplinarydiabetesDepressionQDiabetesRBrainASSOCIATIONriskitekijätMiddle AgedhumanitiesPREVALENCEINVENTORY-IIMedicineFemalegeneettiset tekijätmasennusQuality of lifeRiskmedicine.medical_specialtySciencePopulation stratificationRisk AssessmentArticle03 medical and health sciencesAntigens CDInternal medicineSadnessHumansGenetic Predisposition to DiseaseMETAANALYSISDepressive symptoms030304 developmental biologyAgedHealth related quality of lifePsychiatric Status Rating ScalesDepressive Disorderbusiness.industryterveydentilaInsulin Receptor GeneBeck Depression InventoryReceptor InsulinPSYCHOMETRIC PROPERTIESCross-Sectional StudiesGene Expression Regulation3121 General medicine internal medicine and other clinical medicinebusinessBody mass indexRESISTANCE030217 neurology & neurosurgery
researchProduct

Chapter 33 Experimental human models of neuropathic pain

2006

Publisher Summary This chapter reviews human surrogate models of neuropathic pain that focus on the mechanisms of symptom generation. A vast array of human surrogate models exists for ongoing symptoms, for positive sensory symptoms, and for sensory loss. The chapter discusses that by design, human surrogate models of neuropathic pain involve a reversible modulation of the properties of the nociceptive system such as its acute plasticity (phase 2). They usually do not create a long-lasting and potentially irreversible modification (phase 3). The denervation and ectopic activity of phase 3 can be modeled to a certain extent by transient nerve compression–ischemia and by topical capsaicin. By …

DenervationNociceptionTopical capsaicinbusiness.industryNeuropathic painMedicineSensory lossSensory systemSensory symptomsbusinessNeuroscience
researchProduct

Associations of nutrition and body composition with cardiovascular disease risk factors in soldiers during a 6-month deployment

2020

Objectives This observational follow-up study investigated the associations of nutrition and body composition with cardiovascular disease (CVD) risk factors, including pro-inflammatory biomarkers, in soldiers during a 6-month deployment. Material and Methods Thirty-five male soldiers were assessed at months 0, 3 and 6, and their parameters, i.e., M±SD, were as follows: age 30.0±8.7 years, height 179±6 cm, and BMI 24.2±2.5 kg/m 2 . Three-day food diaries were used for monitoring macronutrient intake. Body composition was estimated using bioimpedance. Fasting blood samples for lipids and pro-inflammatory biomarkers were collected, and blood pressure measurements were performed. Results Carboh…

Dietary FiberMaleSYMPTOMSkolesteroliPhysical fitness0211 other engineering and technologieslcsh:MedicinePROTEINBlood lipidsPhysiologyBLOOD-PRESSURE02 engineering and technologyruokavaliotBody fat percentagesoldierchemistry.chemical_compoundFiber intakeRisk FactorsMedicinesotilaatLebanonFinland05 social sciencesblood pressureGeneral MedicinerauhanturvaoperaatiotDiet Records3142 Public health care science environmental and occupational health0506 political sciencebody fatMilitary PersonnelAdipose TissueCardiovascular DiseasesLow-density lipoproteinBody CompositionSERUM-LIPIDSComposition (visual arts)3143 NutritionAdultPHYSICAL-FITNESS050601 international relationsINFLAMMATIONterveysvaikutuksetHumanscrisis managementkehonkoostumus021110 strategic defence & security studiesCholesterolbusiness.industryterveydentilalcsh:RPublic Health Environmental and Occupational HealthcholesterolCholesterol LDLfiber intakeDietverenpaineBlood pressurechemistryFATravintokuitubusinessInternational Journal of Occupational Medicine and Environmental Health
researchProduct

Cyclic antibiotic therapy for diverticular disease: a critical reappraisal.

2010

Different symptoms have been attributed to uncomplicated diverticular disease (DD). Poor absorbable antibiotics are largely used for uncomplicated DD, mainly for symptom treatment and prevention of diverticulitis onset. Controlled trials on cyclic administration of rifaximin in DD patients were evaluated. Four controlled, including 1 double-blind and 3 open-label, randomized studies were available. Following a long-term cyclic therapy, a significant difference emerged in the global symptoms score (range: 0-18) between rifaximin plus fibers (from 6-6.5 to 1-2) and fibers alone (from 6.7 to 2-3.8), although the actual clinically relevance of such a very small difference remains to be ascertai…

Dietary FiberSettore MED/12 - GastroenterologiaEvidence-Based MedicinePatient SelectionRifamycinsDrug Administration ScheduleRifaximinAnti-Bacterial AgentsDiverticulumSettore MED/18 - Chirurgia GeneraleTreatment Outcomediverticular disease; diverticulitis; haemorrhage; rifaximin; symptoms; therapyHumansDiverticular diseasetherapysymptoms rifaximin diverticulitisDiverticulitis
researchProduct

Cognitive and behavioural effects induced by social stress plus MDMA administration in mice

2017

Adverse life experiences such as social stress may make an individual more vulnerable to drug addiction and mental disorders associated with drug consumption. The present work aimed to evaluate the effects of stress induced by acute social defeat combined with the administration of 3,4-methylenedioxymethamphetamine (MDMA) on depression-like behaviour, memory function and motor response to drug in late adolescent male mice. Two groups of mice were exposed to social defeat (SD) during four encounters with an aggressive co-specific, which took place on alternate days. Immediately after defeat, animals were treated with saline or MDMA 10mg/kg (SD+SAL and SD+MDMA). In control groups, mice were p…

Dominance-SubordinationMalemedicine.medical_specialtyN-Methyl-34-methylenedioxyamphetaminemedia_common.quotation_subjectPoison controlBehavioral SymptomsMotor ActivityBody TemperatureSocial defeatMice03 medical and health sciencesBehavioral Neurosciencechemistry.chemical_compound0302 clinical medicineCorticosteroneInternal medicinemental disordersAvoidance LearningmedicineAnimalsPsychiatrymedia_commonSocial stressAnalysis of VarianceAddictionRecognition PsychologyMDMAmedicine.diseaseTail suspension test030227 psychiatrySubstance abuseDisease Models AnimalEndocrinologyHindlimb SuspensionchemistryHallucinogensCognition DisordersCorticosteronePsychologyStress Psychologicalpsychological phenomena and processes030217 neurology & neurosurgerymedicine.drugBehavioural Brain Research
researchProduct

Interactions and Monitoring of Antipsychotic Drugs

2012

As a consequence of individualized antipsychotic pharmacotherapy, many patients need more than a single drug, since they do not respond sufficiently to monotherapy. Other patients suffer from comorbid diseases and therefore require additional drugs from other pharmacological classes. Drug combinations, however, can give rise to pharmacokinetic and/or pharmacodynamic drug–drug interactions. Evaluation of pharmacokinetic interactions with antipsychotic drugs must consider substrate, inhibitor, and inducer properties for the cytochrome P450 (CYP) isoenzymes of all combined drugs. For consideration of pharmacodynamic interactions, special attention must be given to effects on dopamine D2, hista…

Drugmedicine.diagnostic_testbusiness.industrymedicine.medical_treatmentmedia_common.quotation_subjectPharmacologyPharmacotherapyPharmacokineticsExtrapyramidal symptomsTherapeutic drug monitoringPharmacodynamicsDopamine receptor D2Medicinemedicine.symptombusinessAntipsychoticmedia_common
researchProduct

Cáncer en los primeros 18 meses de vida

2020

Resumen: Introducción: La enfermedad oncohematológica continúa siendo la primera causa de mortalidad no traumática en la infancia y una importante causa de morbilidad. El paciente menor de 18 meses presenta particularidades clínicas, diagnósticas y terapéuticas que es interesante conocer por todo pediatra, con el fin de lograr una mayor supervivencia y una menor comorbilidad a lo largo de su vida. Material y métodos: Estudio descriptivo retrospectivo de variables clínicas, diagnósticas y terapéuticas en pacientes menores de 18 meses diagnosticados de enfermedad oncohematológica que reciben quimioterapia en una unidad de oncología pediátrica entre enero 2007 y agosto 2019. Resultados: Setent…

Early infancyLife-threatening symptoms03 medical and health sciences0302 clinical medicineToxicity030225 pediatricsPediatrics Perinatology and Child HealthChemotherapyChemotherapy Early infancy Embryonic tumours Life-threatening symptoms Primera infancia Quimioterapia Síntomas amenazantes para la vida Toxicidad Toxicity Tumores embrionariosEmbryonic tumoursPediatricsRJ1-570Anales de Pediatría
researchProduct